Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods-Reference-Cited by-同舟云学术

Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods

Published:2015-03 Issue:1 Volume:25 Page:63-70
ISSN:1156-5233
Container-title:Journal de Mycologie Médicale
language:en
Short-container-title:Journal de Mycologie Médicale

Author:

Semis R.,Nahmias M.,Lev S.,Frenkel M.,Segal E.

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference32 articles.

1. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp;Arikan;Antimicrob Agents Chemother,2002

2. Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B;Banerjee;PLoS One,2014

3. Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial);Caillot;Cancer,2007

4. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, Second Edition: Approved Standard M38-A2;Clinical, Laboratory Standards Institute,2008

5. Antifungal therapy;de Pauw;Transplant Proc,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifúngicos: lo que tenemos, lo que tendremos, lo que queremos.;Investigación Clínica;2023-11-22

2. Reviving the interest in the versatile drug nystatin: A multitude of strategies to increase its potential as an effective and safe antifungal agent;Advanced Drug Delivery Reviews;2023-08

3. In Vitro additive effect on griseofulvin and terbinafine combinations against multidrug-resistant dermatophytes;Brazilian Journal of Pharmaceutical Sciences;2018-07-26

4. Diagnostic Aspects of Veterinary and Human Aspergillosis;Frontiers in Microbiology;2018-06-21

5. Risk Assessment Integrated QbD Approach for Development of Optimized Bicontinuous Mucoadhesive Limicubes for Oral Delivery of Rosuvastatin;AAPS PharmSciTech;2018-01-31